Biotage AB Increases Focus on Environmental Market Segments.

STOCKHOLM, Sweden -- Regulatory News:

Biotage AB (STO:BIOTA), a leading supplier of tools and technology for medicinal and analytical chemistry, announces plans to increase its focus on growing business opportunities in the environmental analysis business. The strategy includes redeployed marketing and sales resources along with new product development for specific application areas.

In late 2007 Biotage launched EVOLUTE ABN 50 um; a new SPE sorbent optimized for analysis of environmental contaminants in water. Biotage has near term development plans for several other products to strengthen its environmental offering.

"Purity is essential for reliable quantification at trace levels for environmental applications. Leading environmental labs routinely use Biotage ISOLUTE SPE cartridges for sample preparation when monitoring EPH (extractable petroleum hydrocarbons) in soil and water." said Scott Carr, Vice President Commercial Operations, Biotage.

Since acquiring the analytical consumable business from Argonaut Technologies in June 2005, Biotage has grown the business every year. Biotage CEO, Torben Jorgensen, says "This is a very important area of growth for Biotage as requirements from Environmental Agencies become more stringent and rapidly developing regions of the world intensify their focus on Environmental concerns. Biotage has high-performance, high-quality products that help scientists meet increasingly tougher guidelines with greater efficiency."

About Biotage

Biotage is a global company active in life science research with strong technologies, a broad range of operations and a long-term view of the market. The company offers solutions, knowledge and experience in the areas of genetic analysis and medicinal chemistry. In 2005 operations and products were acquired from the American company Argonaut, further strengthening the medicinal chemistry product range. The customers include the worlds top 30 pharmaceutical companies, the worlds top 20 biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has offices in the U.S., Japan, UK, Germany and several other European countries. Biotage has 336 employees and had sales of 496,4 MSEK in 2007. Biotage is listed on the OMX Nordic Exchange Stockholm AB. Website: www.biotage.com

This information was brought to you by Cision http://newsroom.cision.com